Literature DB >> 9438682

Video-assisted thoracoscopic surgery for resection of lung metastases.

R D Dowling1, R J Landreneau, D L Miller.   

Abstract

Resection of indeterminate pulmonary lesions in patients with a history of malignancy is indicated, as the presence of metastases will provide prognostic information and often dictate further therapy. Pulmonary metastasectomy also improves survival in select patients with favorable tumor histologies. We reported the results of video-assisted thoracoscopic surgery (VATS) resection of indeterminate lung nodules in 72 patients with a history of malignancy. All lesions identified on preoperative high-resolution CT scan were found at surgery with visual inspection, digital palpation, or (in 13 cases) CT-guided needle localization. All lesions were resected nonanatomically with a rim of normal parenchyma, as is done with open techniques; 63 patients were found to have metastases and 9 patients had benign disease. There was no mortality, minimal morbidity, and decreased hospital stays in patients undergoing VATS resection compared with historical control subjects. These data and other reports have led to the widespread use of VATS for patients undergoing resection to establish a diagnosis. The role of VATS in patients with favorable tumor histology and limited tumor burden for whom metastasectomy may result in a survival advantage remains controversial. Improved image resolution with spiral CT scans and digital palpation, combined with intraoperative ultrasound examination of the lung, may decrease or eliminate the number of lesions missed with a VATS approach. The role of therapeutic VATS metastasectomy remains to be defined. Thus, this procedure currently should be used only in clinical trials.

Entities:  

Mesh:

Year:  1998        PMID: 9438682     DOI: 10.1378/chest.113.1_supplement.2s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Pulmonary arterial balloon occlusion during video-assisted thoracoscopic surgery for reduction of the risk of massive hemorrhage.

Authors:  T Onuki; M Murasugi; T Ikeda; K Oyama; S Nitta
Journal:  Surg Endosc       Date:  2001-10       Impact factor: 4.584

2.  Thoracoscopic surgery and conventional open thoracotomy in metastatic lung cancer.

Authors:  J Nakajima; S Takamoto; M Tanaka; E Takeuchi; T Murakawa; T Fukami
Journal:  Surg Endosc       Date:  2001-05-07       Impact factor: 4.584

Review 3.  Intrathoracoscopic localization techniques. Review of literature.

Authors:  D Sortini; C Feo; K Maravegias; P Carcoforo; E Pozza; A Liboni; A Sortini
Journal:  Surg Endosc       Date:  2006-05-13       Impact factor: 4.584

4.  Transmediastinal approach to exploring the lung contralateral to the thoracotomy site.

Authors:  K Kodama; M Higashiyama; H Yokouchi; K Takami; Y Doki; T Kabuto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-05

5.  Thoracoscopic surgery for pulmonary metastases after chemotherapy using a tailor-made virtual lung.

Authors:  Tadashi Akiba; Hideki Marushima; Noriteru Kamiya; Makoto Odaka; Satoki Kinoshita; Hiroshi Takeyama; Toshiaki Morikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

Review 6.  Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules.

Authors:  Farise Yilmaz; Gungor Tastekin
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Thoracoscopic resection of solitary lung metastases evaluated by using thin-section chest computed tomography: is thoracoscopic surgery still a valid option?

Authors:  Kook Nam Han; Chang Hyun Kang; In Kyu Park; Young Tae Kim
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-07

8.  Interstitial laser photocoagulation of normal lung parenchyma in rats.

Authors:  D I Fielding; G Buonaccorsi; A Hanby; M R Hetzel; S G Bown
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

9.  [Surgical therapy of lung metastases-indications, technique, results].

Authors:  A Stier; C-D Heidecke
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.